Telix Pharmaceuticals Limited (TLX.AX)
AUD 29.27
(-0.17%)
AUD 29.27
(-0.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -105.79 Million AUD | 0.09% |
| 2022 | -105.88 Million AUD | -443.05% |
| 2021 | -19.49 Million AUD | 74.26% |
| 2020 | -75.73 Million AUD | -78.35% |
| 2019 | -42.46 Million AUD | -76.64% |
| 2018 | -24.04 Million AUD | 50.34% |
| 2017 | -48.41 Million AUD | 0.0% |
| 2000 | -2.99 Million AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -96.69 Million AUD | 0.0% |
| 2023 Q2 | -118.62 Million AUD | 0.0% |
| 2023 Q4 | -105.79 Million AUD | 0.0% |
| 2023 FY | -105.79 Million AUD | 0.09% |
| 2022 Q4 | -105.88 Million AUD | 0.0% |
| 2022 FY | -105.88 Million AUD | -443.05% |
| 2022 Q2 | -120.04 Million AUD | 0.0% |
| 2021 FY | -19.49 Million AUD | 74.26% |
| 2021 Q4 | -19.49 Million AUD | 0.0% |
| 2021 Q2 | -47.91 Million AUD | 0.0% |
| 2020 FY | -75.73 Million AUD | -78.35% |
| 2020 Q4 | -75.73 Million AUD | 0.0% |
| 2020 Q2 | -21.3 Million AUD | 0.0% |
| 2019 Q2 | -8.34 Million AUD | 0.0% |
| 2019 Q4 | -42.46 Million AUD | 0.0% |
| 2019 FY | -42.46 Million AUD | -76.64% |
| 2018 Q4 | -24.04 Million AUD | 0.0% |
| 2018 FY | -24.04 Million AUD | 50.34% |
| 2018 Q2 | -26.01 Million AUD | 0.0% |
| 2017 Q4 | -48.41 Million AUD | 0.0% |
| 2017 Q2 | -5.9 Million AUD | 0.0% |
| 2017 FY | -48.41 Million AUD | 0.0% |
| 2000 FY | -2.99 Million AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -12417.201% |
| Acrux Limited | -1.45 Million AUD | -7155.967% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -5701.301% |
| Biome Australia Limited | -1.56 Million AUD | -6669.358% |
| BTC Health Limited | -2.02 Million AUD | -5131.646% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -3365.181% |
| CSL Limited | 15.76 Billion AUD | 100.671% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 22.5% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 42.187% |
| Noxopharm Limited | -2.31 Million AUD | -4460.143% |
| PharmAust Limited | -9.71 Million AUD | -989.055% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -1572.905% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -940.984% |
| PYC Therapeutics Limited | -65.76 Million AUD | -60.872% |
| Race Oncology Limited | -17.18 Million AUD | -515.47% |
| Starpharma Holdings Limited | -19.83 Million AUD | -433.441% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -459.783% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | -33.394% |
| Memphasys Limited | 4.13 Million AUD | 2658.222% |
| Nyrada Inc. | -4.76 Million AUD | -2118.153% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -10671.942% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -14809.563% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 2187.726% |
| Patrys Limited | -2.24 Million AUD | -4621.464% |
| Dimerix Limited | -21.99 Million AUD | -381.052% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -518.884% |
| Orthocell Limited | -19.92 Million AUD | -430.958% |
| Imugene Limited | -91.56 Million AUD | -15.543% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -1604.833% |
| Immutep Limited | -122.18 Million AUD | 13.42% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -732.064% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -747.703% |
| Nanollose Limited | -96.22 Thousand AUD | -109842.323% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -1655.864% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -2035.425% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -8442.574% |
| Biotron Limited | -386.06 Thousand AUD | -27302.427% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -469.538% |
| Tissue Repair Ltd | -16.44 Million AUD | -543.463% |
| AnteoTech Limited | -5 Million AUD | -2015.195% |
| Hexima Limited | -2.22 Million AUD | -4652.104% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -501.724% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -3015.071% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -1885.122% |
| Actinogen Medical Limited | -9.13 Million AUD | -1058.518% |
| Immuron Limited | -11.48 Million AUD | -821.227% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -564.829% |